The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASEI.L Regulatory News (ASEI)

  • There is currently no data for ASEI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kepler Trust Intelligence: New Research

10 Nov 2020 07:00

RNS Number : 7459E
Aberdeen Standard Equity Income Tst
10 November 2020
 

Aberdeen Standard Equity Income: New research

10/11/2020

ASEI targets above-average income and capital growth with an index-agnostic approach...

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

 

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAPFNELKEFFA
Date   Source Headline
10th Feb 202211:18 amRNSNet Asset Value(s)
9th Feb 202211:10 amRNSNet Asset Value(s)
8th Feb 202211:19 amRNSNet Asset Value(s)
7th Feb 20221:22 pmRNSGearing disclosure
7th Feb 202212:20 pmRNSNet Asset Value(s)
7th Feb 202210:40 amRNSMonth End Net Asset Value(s)
4th Feb 20222:50 pmRNSNet Asset Value(s)
4th Feb 202212:59 pmRNSDividend Declaration
4th Feb 202212:51 pmRNSResult of AGM
3rd Feb 202211:19 amRNSNet Asset Value(s)
2nd Feb 202212:43 pmRNSNet Asset Value(s)
31st Jan 20223:45 pmRNSGearing disclosure
31st Jan 202212:50 pmRNSNet Asset Value(s)
28th Jan 202212:17 pmRNSNet Asset Value(s)
27th Jan 202211:29 amRNSNet Asset Value(s)
26th Jan 202211:52 amRNSNet Asset Value(s)
25th Jan 202211:52 amRNSNet Asset Value(s)
24th Jan 20222:51 pmRNSGearing disclosure
24th Jan 202211:39 amRNSNet Asset Value(s)
21st Jan 20221:18 pmRNSNet Asset Value(s)
20th Jan 202211:58 amRNSNet Asset Value(s)
19th Jan 202211:42 amRNSNet Asset Value(s)
18th Jan 202212:22 pmRNSNet Asset Value(s)
17th Jan 20224:27 pmRNSGearing disclosure
17th Jan 202212:13 pmRNSNet Asset Value(s)
17th Jan 202211:35 amRNSPortfolio disclosure
14th Jan 202210:25 amRNSNet Asset Value(s)
13th Jan 202211:36 amRNSNet Asset Value(s)
12th Jan 202212:08 pmRNSNet Asset Value(s)
11th Jan 202212:04 pmRNSNet Asset Value(s)
11th Jan 202210:38 amRNSMonth End Net Asset Value(s)
10th Jan 20221:20 pmRNSGearing disclosure
10th Jan 202211:23 amRNSNet Asset Value(s)
7th Jan 202210:24 amRNSNet Asset Value(s)
6th Jan 202210:58 amRNSNet Asset Value(s)
5th Jan 20225:17 pmRNSQuarterly disclosure
5th Jan 202212:09 pmRNSNet Asset Value(s)
4th Jan 20224:30 pmRNSGearing disclosure
31st Dec 202112:22 pmRNSNet Asset Value(s)
30th Dec 202111:31 amRNSNet Asset Value(s)
29th Dec 20213:19 pmRNSGearing disclosure
29th Dec 202111:29 amRNSNet Asset Value(s)
24th Dec 202111:20 amRNSNet Asset Value(s)
23rd Dec 202112:49 pmRNSNet Asset Value(s)
23rd Dec 202112:38 pmRNSDoc re. Annual Report
22nd Dec 202111:49 amRNSNet Asset Value(s)
21st Dec 202111:42 amRNSNet Asset Value(s)
20th Dec 20212:37 pmRNSGearing disclosure
20th Dec 202112:07 pmRNSNet Asset Value(s)
17th Dec 202112:32 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.